Form 4: Hims & Hers Health, Inc. Director Carroll Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director and Chief Medical Officer Patrick Harrison Carroll reports acquisition and disposal of Hims & Hers Health, Inc. Class A Common Stock and Restricted Stock Units.

Summary

  • On March 14, 2025, Patrick Harrison Carroll, Chief Medical Officer and Director of Hims & Hers Health, Inc., acquired 36,275 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
  • On the same day, 3,162 shares were withheld by the issuer to cover tax obligations related to the RSU vesting at a price of $33.14.
  • On March 18, 2025, Carroll sold 23,287 shares of Class A Common Stock at a price of $34.31.
  • Following these transactions, Carroll directly owns 209,661 shares of Class A Common Stock.
  • Carroll also holds 57,041 and 58,075 Restricted Stock Units after the reported transactions.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard disclosure of stock transactions by an insider. There is no indication of positive or negative sentiment towards the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives and directors of publicly traded companies. These transactions are subject to regulatory scrutiny to prevent insider trading.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership by a company insider.

Key Dates

DateDescription
11/08/2024Date of adoption of Rule 10b5-1 trading plan
03/14/2025Acquisition of Class A Common Stock via RSU vesting and tax withholding.
03/18/2025Sale of Class A Common Stock.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.